(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA DE COMBINAÇÃO COM APILIMOD E AGENTES GLUTA-MATÉRGICOS

ArquivadaInvention PatentPCT · US2019018662

Application data

Number

112020016256

Type

Invention Patent

Filing

02/20/2019

Publication

12/15/2020

PCT

US2019018662

Progress at the INPI

  1. Filing02/20/19
  2. Publication12/15/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/17/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AI THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

H. L. (pessoa física)

US

J. R. (pessoa física)

US

P. Y. (pessoa física)

US

S. L. (pessoa física)

US

Technical data

Priority claims

US

62/633,335 · 02/21/2018

Abstract

A presente invenção refere-se a composições e métodos relacionados ao uso do apilimod em combinação com agentes glutamatérgicos para o tratamento de doenças e transtornos neurológicos, e para o tratamento do câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

09/17/2024

RPI 2802

Parecer de pré-exame

#6.23

05/28/2024

RPI 2786

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

12/15/2020

RPI 2606

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.